MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 115 filers reported holding MIRATI THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,130 | +24.6% | 4,778 | +375.4% | 0.01% | +75.0% |
| Q3 2020 | $167,000 | +943.8% | 1,005 | +730.6% | 0.01% | +700.0% |
| Q4 2019 | $16,000 | -93.1% | 121 | -96.0% | 0.00% | -90.0% |
| Q3 2019 | $233,000 | +67.6% | 2,993 | +1.4% | 0.01% | +25.0% |
| Q3 2018 | $139,000 | +531.8% | 2,951 | -10.6% | 0.01% | +300.0% |
| Q3 2016 | $22,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |